Cantimer

Cantimer was a biotechnology company focused on developing a label-free biosensor platform for rapid molecular diagnostics. The company's technology utilized microcantilever sensors to detect specific biomolecules in real-time, aiming to provide high sensitivity and specificity for point-of-care applications. Its primary focus areas included the detection of infectious diseases and cancer biomarkers. The platform was designed to offer real-time results with minimal sample preparation, targeting the decentralized testing market. Although the technology showed promise for point-of-care diagnostics, the company eventually ceased operations.